4-氧代-4,5-二氢-3H-吡咯并[2,3-c]喹啉-1-羧酸
![4-氧代-4,5-二氢-3H-吡咯并[2,3-c]喹啉-1-羧酸结构式](https://image.chemsrc.com/caspic/315/503272-05-7.png)
4-氧代-4,5-二氢-3H-吡咯并[2,3-c]喹啉-1-羧酸结构式
|
常用名 | 4-氧代-4,5-二氢-3H-吡咯并[2,3-c]喹啉-1-羧酸 | 英文名 | 4-oxo-3,5-dihydropyrrolo[2,3-c]quinoline-1-carboxylic acid |
|---|---|---|---|---|
| CAS号 | 503272-05-7 | 分子量 | 228.20400 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C12H8N2O3 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 中文名 | 4-氧代-4,5-二氢-3H-吡咯并[2,3-c]喹啉-1-羧酸 |
|---|---|
| 英文名 | 4-oxo-3,5-dihydropyrrolo[2,3-c]quinoline-1-carboxylic acid |
| 分子式 | C12H8N2O3 |
|---|---|
| 分子量 | 228.20400 |
| 精确质量 | 228.05300 |
| PSA | 86.21000 |
| LogP | 2.11990 |
|
~97%
4-氧代-4,5-二氢-3H-... 503272-05-7 |
| 文献：Pierre Fabre Medicament Patent: US2009/42876 A1, 2009 ; Location in patent: Page/Page column 20 ; |
|
~0%
4-氧代-4,5-二氢-3H-... 503272-05-7 |
| 文献：Pierre Fabre Medicament Patent: US2009/42876 A1, 2009 ; Location in patent: Page/Page column 22 ; |
|
~%
4-氧代-4,5-二氢-3H-... 503272-05-7 |
| 文献：Bergman, Jan; Rehn, Stanley Tetrahedron, 2002 , vol. 58, # 45 p. 9179 - 9185 |
|
~%
4-氧代-4,5-二氢-3H-... 503272-05-7 |
| 文献：Bergman, Jan; Rehn, Stanley Tetrahedron, 2002 , vol. 58, # 45 p. 9179 - 9185 |
|
~%
4-氧代-4,5-二氢-3H-... 503272-05-7 |
| 文献：Bergman, Jan; Rehn, Stanley Tetrahedron, 2002 , vol. 58, # 45 p. 9179 - 9185 |
![ethyl 4-oxo-4,5-dihydro-3H-pyrrolo[2,3-c]quinoline-1-carboxylate结构式](https://image.chemsrc.com/caspic/240/503271-96-3.png)
![4-氧代-4,5-二氢-3H-吡咯并[2,3-c]喹啉-1-甲腈结构式](https://image.chemsrc.com/caspic/353/503272-04-6.png)
![4-氧代-4,5-二氢-3H-吡咯并[2,3-c]喹啉-1-羧酰胺结构式](https://image.chemsrc.com/caspic/283/918474-13-2.png)
